Genexine Decides on 100 Billion KRW Paid-in Capital Increase
[Asia Economy Reporter Lee Jung-yoon] Genexine announced on the 26th that it has decided to conduct a paid-in capital increase through a rights offering followed by a general public offering of forfeited shares, amounting to 100 billion KRW, to raise operating funds.
The new shares consist of 5,797,102 common shares, with an issue price of 17,250 KRW per share.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- New Zealand to Cut 8,700 Civil Servants...14% Reduction Deemed 'Unsustainable and Unviable'
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Additionally, Genexine has also decided on a bonus issue, allocating 0.3 shares for every 1 common share held.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
